BRPI0815597A2 - Formulações de emulsões com derivado de pirazolona - Google Patents
Formulações de emulsões com derivado de pirazolonaInfo
- Publication number
- BRPI0815597A2 BRPI0815597A2 BRPI0815597-6A2A BRPI0815597A BRPI0815597A2 BR PI0815597 A2 BRPI0815597 A2 BR PI0815597A2 BR PI0815597 A BRPI0815597 A BR PI0815597A BR PI0815597 A2 BRPI0815597 A2 BR PI0815597A2
- Authority
- BR
- Brazil
- Prior art keywords
- pirazolona
- formulations
- emulsions
- derivative
- derivative emulsions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98970707P | 2007-11-21 | 2007-11-21 | |
PCT/US2008/082842 WO2009067343A1 (en) | 2007-11-21 | 2008-11-07 | Pyrazolone derivative emulsion formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0815597A2 true BRPI0815597A2 (pt) | 2014-09-30 |
Family
ID=40642635
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0815597-6A2A BRPI0815597A2 (pt) | 2007-11-21 | 2008-11-07 | Formulações de emulsões com derivado de pirazolona |
Country Status (13)
Country | Link |
---|---|
US (1) | US8168670B2 (pt) |
EP (1) | EP2230912A4 (pt) |
JP (1) | JP5509090B2 (pt) |
KR (2) | KR101235085B1 (pt) |
CN (1) | CN101801195A (pt) |
AR (1) | AR069386A1 (pt) |
AU (1) | AU2008326593B2 (pt) |
BR (1) | BRPI0815597A2 (pt) |
CA (1) | CA2695605C (pt) |
EA (1) | EA018458B1 (pt) |
TW (1) | TWI376240B (pt) |
WO (1) | WO2009067343A1 (pt) |
ZA (1) | ZA201000780B (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101966149B (zh) * | 2010-09-25 | 2012-02-15 | 西安力邦制药有限公司 | 一种脑梗塞治疗药物脂肪乳剂的制备 |
US8747534B2 (en) * | 2010-12-29 | 2014-06-10 | United States Gypsum Company | Antimicrobial size emulsion and gypsum panel made therewith |
CN102058531B (zh) * | 2011-01-11 | 2012-09-19 | 西安力邦制药有限公司 | 一种脑保护治疗药物脂肪乳剂的制备 |
CN109125261B (zh) * | 2016-03-16 | 2021-11-30 | 苏州澳宗生物科技有限公司 | 依达拉奉剂型 |
EP3785703A1 (en) * | 2017-01-17 | 2021-03-03 | Treeway TW001 B.V. | Treatment comprising oral or gastric administration of edaravone |
CN109431966B (zh) * | 2018-04-27 | 2020-09-22 | 首都医科大学附属北京天坛医院 | 依达拉奉药物组合物 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4185100A (en) * | 1976-05-13 | 1980-01-22 | Johnson & Johnson | Topical anti-inflammatory drug therapy |
JPS5931689B2 (ja) * | 1978-01-23 | 1984-08-03 | 富士写真フイルム株式会社 | 油溶性写真用添加剤の分散方法 |
US4360518A (en) * | 1979-08-06 | 1982-11-23 | Johnson & Johnson | Topical anti-inflammatory drug therapy |
DE3308881A1 (de) * | 1983-03-12 | 1984-09-13 | Bayer Ag, 5090 Leverkusen | Verwendung von pyrazolonderivaten als lipoxygenasehemmer, bei der therapie von ischaemien und herzrhythmusstoerungen sowie von rheumatischen, allergischen und asthmatischen erkrankungen, oedemen, lungenembolien, pulmonaler hypertension, sauerstoffintoxikation und ulcerationen, arzneimittel hierfuer und verfahren zu deren herstellung |
DE3312581A1 (de) * | 1983-04-08 | 1984-10-11 | Bayer Ag, 5090 Leverkusen | Verwendung von pyrazolonderivaten bei der bekaempfung des wachstums von tumorzellen und der metastasenbildung, arzneimittel hierfuer und verfahren zu deren herstellung |
US6455525B1 (en) * | 1999-11-04 | 2002-09-24 | Cephalon, Inc. | Heterocyclic substituted pyrazolones |
ATE428470T1 (de) * | 2000-06-29 | 2009-05-15 | Mei Co Ltd | Heilmittel zur behandlung von erkrankungen des sehnervs |
KR100921199B1 (ko) * | 2001-05-11 | 2009-10-13 | 미쓰비시 타나베 파마 코퍼레이션 | 안정하고 고농도인 피라졸론 유도체를 포함하는 주사제 |
KR20050114606A (ko) * | 2003-01-10 | 2005-12-06 | 미츠비시 웰파마 가부시키가이샤 | 혈액뇌관문 파탄 억제제 |
CN1440749A (zh) * | 2003-03-24 | 2003-09-10 | 南昌弘益科技有限公司 | 易达拉封注射剂及其制备工艺——治疗急性脑梗塞 |
DE102004025357B4 (de) | 2004-05-19 | 2007-03-29 | Beiersdorf Ag | Emulsionskonzentrat mit wasserlöslichen und öllöslichen Polymeren und kosmetische Zubereitung enthaltend Emulsionskonzentrat sowie ein Verfahren zu dessen Herstellung und dessen Verwendung |
JP4746856B2 (ja) * | 2004-08-12 | 2011-08-10 | 三笠製薬株式会社 | ピラゾロン系製剤 |
US20070116769A1 (en) * | 2004-11-01 | 2007-05-24 | Novozymes A/S | Continuous encapsulation process |
US20060189682A1 (en) | 2005-02-02 | 2006-08-24 | Payne Joseph E | Water soluble prodrugs of COX-2 inhibitors |
JP2006298774A (ja) * | 2005-04-15 | 2006-11-02 | Lead Chemical Co Ltd | 経皮吸収型フリーラジカル抑制製剤 |
US8158152B2 (en) | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
-
2008
- 2008-11-07 JP JP2010535000A patent/JP5509090B2/ja not_active Expired - Fee Related
- 2008-11-07 BR BRPI0815597-6A2A patent/BRPI0815597A2/pt not_active IP Right Cessation
- 2008-11-07 CN CN200880104981A patent/CN101801195A/zh active Pending
- 2008-11-07 US US12/267,304 patent/US8168670B2/en not_active Expired - Fee Related
- 2008-11-07 KR KR1020107003798A patent/KR101235085B1/ko not_active IP Right Cessation
- 2008-11-07 WO PCT/US2008/082842 patent/WO2009067343A1/en active Application Filing
- 2008-11-07 KR KR1020127027858A patent/KR20120125403A/ko not_active Application Discontinuation
- 2008-11-07 AU AU2008326593A patent/AU2008326593B2/en not_active Ceased
- 2008-11-07 EP EP08852188.5A patent/EP2230912A4/en not_active Withdrawn
- 2008-11-07 CA CA2695605A patent/CA2695605C/en not_active Expired - Fee Related
- 2008-11-07 EA EA201000266A patent/EA018458B1/ru not_active IP Right Cessation
- 2008-11-20 AR ARP080105053A patent/AR069386A1/es not_active Application Discontinuation
- 2008-11-20 TW TW097144785A patent/TWI376240B/zh active
-
2010
- 2010-02-02 ZA ZA2010/00780A patent/ZA201000780B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2009067343A1 (en) | 2009-05-28 |
EP2230912A4 (en) | 2013-05-01 |
CN101801195A (zh) | 2010-08-11 |
US20090131496A1 (en) | 2009-05-21 |
AU2008326593B2 (en) | 2013-09-05 |
TW200936181A (en) | 2009-09-01 |
CA2695605A1 (en) | 2009-05-28 |
TWI376240B (en) | 2012-11-11 |
EA201000266A1 (ru) | 2010-10-29 |
KR101235085B1 (ko) | 2013-02-20 |
JP2011504177A (ja) | 2011-02-03 |
EP2230912A1 (en) | 2010-09-29 |
CA2695605C (en) | 2013-04-09 |
US8168670B2 (en) | 2012-05-01 |
JP5509090B2 (ja) | 2014-06-04 |
ZA201000780B (en) | 2011-04-28 |
AU2008326593A1 (en) | 2009-05-28 |
KR20120125403A (ko) | 2012-11-14 |
KR20100091939A (ko) | 2010-08-19 |
EA018458B1 (ru) | 2013-08-30 |
AR069386A1 (es) | 2010-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2007000084A (es) | Derivados de dihidropirazolopirimidinona | |
DK3492069T3 (da) | Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid | |
BRPI0814805A2 (pt) | Emulsões duplas estáveis | |
BRPI0820381A2 (pt) | Formulações farmacêuticas | |
BRPI0813707A2 (pt) | Derivados de pirimidinil-piridazinona | |
BRPI0820112A2 (pt) | Derivados de isoxazol-piridina | |
BRPI0809992A2 (pt) | Derivados de pirrolopirimidina | |
BRPI0820113A2 (pt) | Derivados de isoxazolo-piridazina | |
BRPI0810634A2 (pt) | Composições fungicidas | |
BRPI0818079A2 (pt) | composição de lipideo | |
BRPI0817935A2 (pt) | Derivados de biarila | |
BRPI0812155A2 (pt) | derivados de espiroindolinona | |
BRPI0814236A2 (pt) | Derivados de quinazolinamida | |
BRPI0812518A2 (pt) | Derivados de indazolamida | |
CR10562A (es) | Nuevos derivados de piridazina | |
BRPI0814188A2 (pt) | Formulações | |
BRPI0820649A2 (pt) | Derivados de isoxazalo-pirazina | |
BRPI0722002A2 (pt) | composições de desodorante | |
DK2190837T3 (da) | 4-pyrimidinsulfamid-derivat | |
CR10809A (es) | Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona | |
BRPI0814718A2 (pt) | Derivados de isoxazol-imidazol | |
BRPI0820198A2 (pt) | composições farmacêuticas | |
BRPI0921947A2 (pt) | formulações de proteína terapêutica | |
BRPI0917210A2 (pt) | exoterma controlada de formulações de cianocrilato | |
BRPI0817442A2 (pt) | Formulações galênicas de composto orgânicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 7A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |